White label ELPA - ClinicalTrials.eu

Study on Osimertinib and Drug Combination for Adults with Unresectable Non-small Cell Lung Cancer

Not recruiting

2 1 1 1
Investigated diseases:
- Non-small cell lung cancer stage III
Investigated drugs:
Study to Identify Unknown Primary Cancer Using [18F]-AlF-FAPI-74 PET-CT for Patients with Carcinoma of Unknown Primary

Not recruiting

3 1 1
Investigated diseases:
- Malignant neoplasm of unknown primary site
Investigated drugs:
- [Al[18F]F]Fapi-74
Study on the Safety and Effects of INZ-701 for Infants with ENPP1 or ABCC6 Deficiency

Not recruiting

1 1 1
Investigated diseases:
- Ectonucleotide pyrophosphatase/phosphodiesterase 1 deficiency
- Arteriosclerosis
Investigated drugs:
- Recombinant Human Ectonucleotide Pyrophosphatase/Phosphodiesterase 1 Fused To The Fc Fragment Of Igg1
Study of Ravulizumab for Adults with Lupus Nephritis or IgA Nephropathy

Not recruiting

2 1 1
Investigated diseases:
- IgA nephropathy
- Lupus nephritis
Investigated drugs:
- Ravulizumab
+1
Study of Tislelizumab, Pamiparib, and Ociperlimab in Patients with Advanced Solid Tumors and Blood Cancers

Not recruiting

3 1 1
Investigated diseases:
- Haematological malignancy
- Neoplasm malignant
Investigated drugs:
Study Comparing DB-1303 and Chemotherapy for Patients with HER2-low, Hormone Receptor Positive, Metastatic Breast Cancer

Not recruiting

3 1 1 1
Investigated diseases:
- Hormone receptor positive breast cancer
- Hormone receptor positive HER2 negative breast cancer
Investigated drugs:
+1
Study on Metformin for Reversing Accelerated Aging in People Aged 50+ Living with HIV

Not recruiting

3 1 1 1
Investigated diseases:
- HIV infection
Investigated drugs:
- Metformin Hydrochloride
Study on Brigatinib for Patients with ALK+ Non-Small Cell Lung Cancer

Not recruiting

2 1 1 1
Investigated diseases:
- Non-small cell lung cancer stage IV
Investigated drugs:
- Brigatinib
Study on the Effects of Dersimelagon Phosphate for Adults and Adolescents with Erythropoietic Protoporphyria or X-Linked Protoporphyria

Not recruiting

3 1
Investigated drugs:
- Dersimelagon Phosphate
+1
Study Comparing Fluciclovine (18F) and Fluoroethyltyrosine F-18 PET Scans in Patients with New or Recurrent Brain Tumors and Brain Metastases

Not recruiting

2 1 1 1
Investigated diseases:
- Glioma
- Metastases to central nervous system
Investigated drugs:
- Fluciclovine (18F)
- Fluoroethyltyrosine F-18

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies